Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

NCT06719531 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT06719531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06719531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2025
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus, type 2 diabetes mellitus